Switch to
More onapp

How to use scorecard? Learn more

Sanofi Consumer Healthcare India Ltd

SANOFICONR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,170 cr, stock is ranked 489
Low RiskStock is 1.65x as volatile as Nifty
4,833.3016.80 (-0.35%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Low

Profitability and efficiency haven't been upto the mark

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,170 cr, stock is ranked 489
Low RiskStock is 1.65x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
53.73
PB RatioPB Ratio
6,570.64
Dividend YieldDiv. Yield
Sector PESector PE
49.58
Sector PBSector PB
6.43
Sector Div YldSctr Div Yld
0.54%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sanofi Consumer Healthcare India Ltd produces and markets a wide range of consumer healthcare products, including pharmaceuticals and nutritional products.

Financial TrendFinancial statements 

20230.00-0.30
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Disclosure under SEBI Takeover Regulations 
Announced OnJan 8, 2025

Hoechst GmbH has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | Download

Hoechst GmbH has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | Download

Disclosure under SEBI Takeover Regulations 
Announced OnJan 7, 2025

Opella Healthcare Participations B. V has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 | Download

Opella Healthcare Participations B. V has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 | Download

Name Change 
Announced OnJan 3, 2025

Change in Name of Registrar and Share Transfer Agent | Download

Change in Name of Registrar and Share Transfer Agent | Download

See all events